EXHIBIT 107
Calculation of Filing Fee Table
FORM S-8
(Form Type)
Rigel Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
| | | Security Type | | Security
Class
Title | | Fee
Calculation
Rule | | Amount
Registered(1) | | | Proposed
Maximum
Offering Price
Per Unit | | Maximum
Aggregate
Offering Price | | Fee Rate | | | Amount of
Registration Fee(2) | |
| Fees to Be Paid | | Equity(3) | | Common Stock, $0.001 par value per share | | Rules 457(c)
and 457(h) | | | 1,079,000 | | | $ | 2.33 | | $ | 2,514,070 | | | .0000927 | | | $ | 233.05 | |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | Total Offering Amounts | | | | | | | | | | | | $ | 233.05 | |
| | | Total Fee Offsets | | | | | | | | | | | | $ | -- | |
| | | Net Fee Due | | | | | | | | | | | $ | 233.05 | |
| (1) | Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, or the Securities Act, this Registration Statement shall also cover any additional shares of Registrant’s Common Stock that become issuable under the plan set forth herein by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected that results in an increase to the number of outstanding shares of Registrant’s Common Stock, as applicable. |
| (2) | Estimated in accordance with Rules 457(c) and 457(h) solely for the purpose of calculating the registration fee on the basis of $2.33 per share, the average of the high and low prices of the Registrant’s Common Stock on February 24, 2022 as reported on the Nasdaq Global Select Market. |
| (3) | Represents shares of the Registrant’s Common Stock that were added to the Inducement Plan pursuant to share reserve increases approved by the Registrant’s Board of Directors. |
